Key Breast Journal Articles - Neoadjuvant
Published: Fri Apr 29, 2011 Updated:Thu Sep 29, 2011
-
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Gianni L. et al; January 2012; Lancet; 13(1); 25-32
-
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Dowsett M. et al; September 29, 2011; JNCI; doi: 10.1093/jnci/djr393
-
A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer
Freedman OC. et al; September 2009; Breast Cancer Res Treat; 119(1); 155-161
-
New results from the use of bisphosphonates in cancer patients
Coleman R. et al; September 2009; Current Opinion Support Palliative Care; 3(3); 213-218
-
Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902
van Nes JGH. et al; May 2009; Breast Cancer Research and Treatment; 115(1); 101-113
-
Neoadjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer: primary efficacy analysis of the NOAH trial
Gianni L. et al; January 15, 2009; Cancer Research; 69(1) S. 1
-
The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathological response – exploratory evidence for direct anti-tumor activity in breast cancer
Winter MC. et al; January 15, 2009; Cancer Research; 69(2) S. 1
-
Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
Rastogi P. et al; February 10, 2008; JCO; 26(5); 778-785
-
Neoadjuvant trastuzumab in locally advanced breast cancer (NOAH): Antitumour and safety analysis
Gianni L. et al; June 20, 2007; JCO. 25(S18); 532
-
Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer
Semiglazov VF. et al; May 30, 2007; Cancer; 110(2); 244-254
-
Neoadjuvant endocrine therapy in breast cancer
Beresford MJ. et al; February 2007; Cancer Treatment Reviews; 33(1); 48-57
-
Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27
Bear HD. et al; May 1, 2006; JCO; 24(13); 2019-27
-
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Updat
Kaufmann M. et al; April 20, 2006; JCO; 24(12); 1940-49
-
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks
Green MC. et al; September 1, 2005; JCO; 23(25); 5983-5992
-
Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) Multicenter Double-Blind Randomized Trial
Smith IE. et al; August 1, 2005; JCO; 23(22); 5108-5116
-
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer
Buzdar AU. et al; June 1, 2005; JCO; 23(16); 3676-85
-
Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?
Freedman OC. et al; February 2005; Cancer Treatment Review; 31(1); 1-17
-
Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
Mauri D. et al; 2005; JNCI; 97(3); 188-194
-
The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27
Bear HD. et al; November 15, 2003; JCO; 21(22); 4165-74
-
Neoadjuvant Chemotherapy in Breast Cancer: Significantly Enhanced Response With Docetaxel
Smith IC. et al; March 2002; JCO; 20(6); 1456-66
-
Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902
van der Hage JA. et al; November 2001; JCO; 19(22); 4224-37
-
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
Eirmann W. et al; 2001; Annals of Oncology; 12(11); 1527-32
-
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
Fisher B. et al; 1998; JCO; 16 ;2672-85
